REHOVOT, Israel -- Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify's InfiniSeq™ library preparation solutions to Romania. This collaboration offers a cost-effective alternative for next-generation sequencing (NGS). Dexter is actively deploying genomic solutions in various laboratories across Romania, expanding access to advanced genomic diagnostics. Sequentify's InfiniSeq reduces sample preparation time to 3.5 hours, from DNA extraction to [...]

Tewksbury, MA – Cambridge Isotope Laboratories, Inc. (CIL), the global leader in 13C and 13C urea production, is excited to announce the startup of its North Star project, significantly increasing the company's production capabilities. The North Star project commenced in mid-2020 as the world’s largest 13C production cascade. After the complex build of phase one [...]

PHC Corporation’s Biomedical Division (headquarters: Chiyoda-ku, Tokyo, President: Nobuaki Nakamura; hereafter Biomedical Division) announced today the commercial launch of LiCellMo, a live cell metabolic analyzer that allows researchers to visualize metabolic(*1) changes in cell cultures, providing a more complete picture of cell activity for research uses in cell and gene therapies (CGT). LiCellMo uses PHC’s proprietary [...]

Durham, NC – EpiCypher®, a trailblazer in epigenetic research technologies, is pleased to announce an exclusive licensing agreement with Fred Hutch Cancer Center. This agreement grants EpiCypher access to pivotal intellectual property (IP) related to CUT&Tag technology, a revolutionary advancement in chromatin profiling developed by renowned scientist Dr. Steven Henikoff, a Fred Hutch molecular biologist [...]

Archer CGP research assays now enable homologous recombination deficiency (HRD) assessment for identification of key biomarkers critical for cancer research CORALVILLE, Iowa — With a history of driving innovation and collaboration in next generation sequencing (NGS), Integrated DNA Technologies is expanding its Archer portfolio of comprehensive genomic profiling (CGP) solutions to include homologous recombination deficiency [...]

Accomplished R&D Leader and CRISPR Tools Expert Joins VedaBio to Drive Platform Expansion and Industrialization SAN DIEGO -- VedaBio, a biotechnology company leading a paradigm shift in molecular detection, today announced the appointment of G. Brett Robb, Ph.D., as Senior Scientific Director and Head of CRISPR Science. With over 16 years of experience in life [...]

DKSH has formed an exclusive partnership with Hygiena®, a global leader in food safety and health diagnostics solutions. DKSH will leverage its market expansion services to enhance Hygiena’s presence in Cambodia, Laos and Myanmar. Camarillo, California – DKSH Business Unit Technology has announced a new, exclusive partnership with Hygiena, a prominent provider in rapid microbial detection, [...]

We’re excited to introduce the newest member of our POROLUX™ Revo series—the POROLUX™ Revo X! The Revo X is tailored for applications with relatively large pores, while demanding the high precision and ease of use that you expect from our POROLUX™ Revo. With the smallest detectable pore size of 80 nm (max. pressure 8 bar), [...]

Highly Accurate Long-Read Sequencing Data from Revio will Support Germany’s National Genome Initiative and Provide Data to the International Male Infertility Consortium MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with the University Hospital of Münster, to use long-read whole genome sequencing to significantly [...]

Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass. -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth [...]